Eric L. Ford
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
-
- Diabetes Treatment and Management
- Diabetes Management and Research
Papers in ⓘ
- Surgery 17
- Pancreatic function and diabetes 10
- Helicobacter pylori-related gastroenterology studies 7
-
- Immune Cell Function and Interaction 4
- IL-33, ST2, and ILC Pathways 4
- Co-authors
- Kenneth S. Polonsky (8 shared papers)Ernesto Bernal‐Mizrachi (2 shared papers)Shin‐ichiro Imai (1 shared paper)Corentin Cras‐Méneur (1 shared paper)Andrew A. Grimm (1 shared paper)M. Alan Permutt (1 shared paper)Burton M. Wice (4 shared papers)Alvin C. Powers (2 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)Cellular and Molecular Gastroenterology and Hepatology (3 papers)Cell Metabolism (2 papers)Diabetes (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesSpainJapan
In The Last Decade
Eric L. Ford
20 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Geriatrics and Gerontology 388
- Endocrinology, Diabetes and Metabolism 551
- Aging 45
- Physiology 108
- Surgery 981
Countries citing papers authored by Eric L. Ford
This map shows the geographic impact of Eric L. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Ford more than expected).
Fields of papers citing papers by Eric L. Ford
This network shows the impact of papers produced by Eric L. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Ford. The network helps show where Eric L. Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric L. Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice Hit paper breakdown → | 2005 | 518 |
| 2 | 2009 | 260 | |
| 3 | 2008 | 148 | |
| 4 | 2008 | 134 | |
| 5 | 2004 | 127 | |
| 6 | 2009 | 103 | |
| 7 | 2010 | 68 | |
| 8 | 2020 | 62 | |
| 9 | 2010 | 60 | |
| 10 | 2009 | 56 | |
| 11 | 2018 | 53 | |
| 12 | 2004 | 52 | |
| 13 | 2019 | 52 | |
| 14 | 2018 | 45 | |
| 15 | 2010 | 41 | |
| 16 | 2021 | 39 | |
| 17 | 2006 | 36 | |
| 18 | 2020 | 23 | |
| 19 | 2018 | 4 | |
| 20 | 2017 | 1 |
About Eric L. Ford
Eric L. Ford is a scholar working on Surgery, Immunology, Endocrinology, Diabetes and Metabolism, Cell Biology and Genetics, having authored 20 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (10 papers), Helicobacter pylori-related gastroenterology studies (7 papers), Diabetes and associated disorders (5 papers), Immune Cell Function and Interaction (4 papers), IL-33, ST2, and ILC Pathways (4 papers), Diabetes Management and Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Geriatrics and Gerontology (388 citations), Endocrinology, Diabetes and Metabolism (551 citations), Aging (45 citations), Physiology (108 citations) and Surgery (981 citations). Eric L. Ford has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Kenneth S. Polonsky, Ernesto Bernal‐Mizrachi, Shin‐ichiro Imai, Corentin Cras‐Méneur, Andrew A. Grimm, M. Alan Permutt, Burton M. Wice, Alvin C. Powers, Lara Nyman and David W. Piston. Their work appears in journals such as Journal of Biological Chemistry, Cellular and Molecular Gastroenterology and Hepatology, Cell Metabolism, Diabetes and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.